The Precision Medicine conference will assess current developments and steps needed to make personalized therapy available to the physicians and patients. This year’s program will explore NGS-assisted healthcare delivery in cancer and non-invasive prenatal testing (NIPT). Using big data analytics to understand results and generate systems to scale is essential to keeping up with the data being accumulated to deliver precision medicine. Innovative approaches to combining targeted therapy approaches with immunotherapy represents a way to increase success rates and lower toxicity of altering the immune system.